Aenitis Technologies Secures Major Funding to Transform Bioproduction with Advanced Acoustofluidic Technology

  Aenitis is set to transform the bioproduction industry by addressing the increasing need for scalable, cost-effective, and highly precise cell ...

October 10, 2024 | Thursday | News
Ascend Strengthens Global Gene Therapy Support with New Multi-Million Dollar Investments in Technology and Flexible Capacity

Continued Investment in Technology & Flexible Capacity, Including New Fill/Finish Capabilities, Fortify the Global Gene Therapy Support Offer at Ascend...

September 25, 2024 | Wednesday | News
Takeda Receives Japanese Approval for FRUZAQLA® (Fruquintinib) in Metastatic Colorectal Cancer Treatment

— Approval based on results from global Phase III FRESCO-2 trial in patients with previously treated metastatic colorectal cancer — &md...

September 24, 2024 | Tuesday | News
PolTREG Secures Chinese Patent for Intrathecal Administration of MS Therapy, Set to Launch Phase 2 Trials

China’s National Intellectual Property Administration has issued notification to grant patent to PolTREG Chinese patent covers intrathecal...

September 16, 2024 | Monday | News
MaxCyte and Kamau Therapeutics Partner to Advance Next-Gen Gene Therapies for Sickle Cell Disease

MaxCyte, Inc.,  a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and comme...

September 16, 2024 | Monday | News
CPC Introduces Innovative Aseptic Micro-Connector for Cell and Gene Therapy Freeze Cassettes

CPC (Colder Products Company), part of Dover  and a leading manufacturer of connection technologies used in biopharmaceutical processing, today...

September 12, 2024 | Thursday | News
FDA Grants RMAT Designation to BridgeBio’s Investigational Gene Therapy BBP-812 for Canavan Disease

- Receipt of RMAT Designation is based on preliminary clinical evidence from the CANaspire Phase 1/2 clinical trial, which showed functional improvements...

September 11, 2024 | Wednesday | News
Hongene Biotech and ReciBioPharm Forge Strategic Alliance to Enhance Gene Editing Drug Manufacturing

Hongene Biotech Corporation, a global leader in nucleic acid manufacturing, and ReciBioPharm, a leading advanced therapeutics CDMO services provider, hav...

September 09, 2024 | Monday | News
Singapore Launches Subsidy Program for Pioneering Cell, Tissue, and Gene Therapies

Singaporean government has introduced a subsidy program to make cell, tissue, and gene therapy products (CTGTP) more accessible to patients. Begi...

September 04, 2024 | Wednesday | News
Genentech Validates Mission Bio's Tapestri Platform for Enhanced Characterization of Gene-Edited T-Cell Therapies

-Mission Bio, a leader in single-cell multiomics solutions for precision medicine, today announced the release of data from scientists at Genentech&rsquo...

August 21, 2024 | Wednesday | News
Alcura Receives MIA License for Cell and Gene Therapies, Expanding CGT Support Across Europe

Alcura, a provider of specialized clinical trial services and a part of Cencora, has been granted a Manufacturing and Importation Authorization (MIA) lic...

August 15, 2024 | Thursday | News
Vertex Pharmaceuticals Secures Landmark Reimbursement Deal with NHS England for First CRISPR Gene-Edited Therapy

Vertex Pharmaceuticals (Nasdaq: VRTX) announced  a reimbursement agreement with NHS England for eligible transfusion-dependent beta thalassemia (TDT...

August 09, 2024 | Friday | News
Integrated DNA Technologies Launches Rapid Genes for Expedited Drug Discovery

To enable pharmaceutical researchers to move quickly into their high‑throughput screening experiments, global genomics solutions provider Integrated DNA ...

August 08, 2024 | Thursday | News
Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy

Agilent that it has received FDA approval for the use of MAGE-A4 IHC 1F9 pharmDx (SK032) as a diagnostic tool to aid in identifying patients with synovia...

August 05, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close